The Vega team and experts regularly work on complex matters involving the healthcare sector and our team has provided economic analyses in both litigation and regulatory investigations. We have experience applying economic theory and econometric modelling to both healthcare markets and healthcare policy topics. Our experts’ knowledge spans multiple industries and specializations, including the intersections of health economics and insurance, and health economics and policy.

Vega and members of its network have extensive experience working with large healthcare datasets, both those that are publicly available and those that have been produced during litigation. Vega regularly analyzes databases containing hundreds of billions of medical records and has state-of-the-art and secure computing facilities to process and manage sensitive healthcare data.

Below is a list of example engagements for our Healthcare & Health Economics practice:

Farasat Bokhari

Senior Lecturer (Associate Professor) in the School of Economics and Centre for Competition Policy at the University of East Anglia

  • Antitrust & Competition
  • Healthcare & Health Economics
  • Insurance & Risk
Ethan Cohen-Cole

Senior Advisor at Vega Economics

  • Securities & Finance
  • Data Science & Statistics
  • Financial Institutions
  • Valuation
  • Consumer Finance
  • Healthcare & Health Economics
Gabriel Picone

Professor in the Department of Economics at University of South Florida

  • Healthcare & Health Economics
Jon M. Riddle

Principal and Senior Economist at ECONOMIC ASSOCIATES

  • Antitrust & Competition
  • Healthcare & Health Economics
  • Valuation
Louis F. Rossiter

Research Professor in the Thomas Jefferson Program in Public Policy at William & Mary

  • Healthcare & Health Economics
  • Antitrust & Competition
Kosuke Uetake

Associate Professor of Marketing in the Yale University School of Management

  • Antitrust & Competition
  • Healthcare & Health Economics
  • Marketing
Andrew Zuppann


  • Healthcare & Health Economics
  • Labor & Employment
August 23, 2021 | Article
The Modern Regulatory Framework for Generic Drugs Encourages Active Price Competition

The regulatory framework for pharmaceuticals has evolved alongside this boom to facilitate the safe and affordable access to medicine as consumers increase their use of generics. This article reviews the historical development of the regulatory framework for generic pharmaceuticals in the U.S. and its economic impact, particularly in facilitating price competition.

April 18, 2021 | News
Relative Obesity and the Formation of Non-cognitive Abilities During Adolescence

Vega Principal Andrew Zuppann's paper on the role of relative childhood and adolescent obesity was recently published in The Journal of Human Resources.

March 25, 2021 | Featured Expert
Dr. Lou Rossiter, Research Professor, Program in Public Policy, William & Mary

Our featured expert, Lou Rossiter, is an expert in health economics. He has served as an expert on numerous cases and most recently he has been retained with the support of the Vega team to provide an analysis of pricing pressure and price fixing in the generic drug market for certain drugs.